This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Granules India Ltd. announced on Friday that it has received approval from the US Food and Drug Administration for tablets ...

The new buprenorphine formulation is used as a substitution treatment in adults and adolescents 15 years or older who agree ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

Granules India's US subsidiary receives FDA approval for generic Bupropion Hydrochloride Extended-Release Tablets, expanding ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

THE Bureau of Customs (BOC) seized ecstasy tablets and methamphetamine hydrochloride or shabu valued at P50.47 million in two separate operations at the Ninoy Aquino International Airport (Naia) and ...

THE Bureau of Customs (BoC) said it has seized around P50.47 million worth of illegal drugs in separate busts recently. At the Manila airport last Oct. 12, a passenger was found carrying 6.2 kilograms ...